Endoscopic stomach reduction for weight loss before kidney transplant
Part of Hormones & metabolism, Kidney & urinary, Women’s health & pregnancy clinical trials.
This trial tests an endoscopic procedure that helps reduce stomach size to support weight loss in people with severe kidney disease who may need a kidney transplant. It may help some patients meet transplant-center weight requirements and potentially improve readiness for transplant care.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 70 years old
- Your body mass index (BMI) is 35 or higher
- You have advanced kidney disease (kidney function is very low) and are expected to need dialysis or may already be on hemodialysis
- You are not on peritoneal dialysis (home dialysis through the belly)
- You can safely undergo general anesthesia and can sign informed consent
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a non-surgical procedure called Endoscopic Sleeve Gastroplasty (ESG) to help people with obesity lose weight. A doctor uses a thin tube with a camera to stitch your stomach smaller, so you feel full sooner.
This study tests a new, non-surgical procedure called Endoscopic Sleeve Gastroplasty (ESG) to help teenagers with severe obesity lose weight. The goal is to see if it can improve their health and help them reach a healthier weight.
This study compares two similar minimally invasive procedures to help with weight loss. The goal is to see which technique is safer and more effective for people with a high body mass index (BMI).
This trial tests a procedure called Endoscopic Sleeve Gastroplasty (ESG) as a non-surgical option for weight loss. It aims to help people who have not been able to lose weight with diet and exercise, and who either cannot or prefer not to have bariatric surgery.
This study tests a weight-loss procedure called endoscopic sleeve gastroplasty, which uses an endoscope (a flexible tube with a camera) to reduce the size of your stomach, helping you eat less and lose weight. It is designed for people who have both obesity and a type of heart failure called HFpEF (heart failure with preserved ejection fraction), and aims to improve heart symptoms and quality of life.
This study tracks people with obesity who get an endoscopic sleeve gastrectomy, a procedure that reduces stomach size without surgery. The goal is to see how safe and effective it is in everyday practice.
Hear when a new Obesity, Morbid trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.